'Hypereosinophilic syndrome' diaporamas de présentation

Hypereosinophilic Syndromes

884 views • 12 slides

Polycythemia Vera

Polycythemia Vera. Aswad H. Al.Obeidy FICMS, FICMS GE&Hep Kirkuk General Hospital. Polycythemia Vera. The World Health Organization (WHO) classification of the chronic myeloproliferative diseases includes seven disorders

395 views • 10 slides

Hypereosinophilic Syndrome Market Analysis-Ken Research

The hypereosinophilic syndrome (HES) is a disease characterized by a persistently elevated eosinophil count (? 1500 eosinophils/mm) in the blood for at least six months without any recognizable cause, with involvement of either the heart, nervous system, or bone marrow. HES is a diagnosis of exclusion, after clonal eosinophilia (such as leukemia) and reactive eosinophilia (in response to infection, autoimmune disease, atopy, hypoadrenalism, tropical eosinophilia, or cancer) have been ruled out. For more information on the research report, visit https://www.kenresearch.com/healthcare/pharmaceuticals/hypereosinophilic-syndrome-pipeline-review-h1-2018/149564-91.html

82 views • 7 slides

Hypereosinophilic Syndrome Market Future Outlook, Market Growth Analysis-Ken Research

The hypereosinophilic syndrome (HES) is a disease characterized by a persistently elevated eosinophil count (? 1500 eosinophils/mm) in the blood for at least six months without any recognizable cause, with involvement of either the heart, nervous system, or bone marrow. HES is a diagnosis of exclusion, after clonal eosinophilia (such as leukemia) and reactive eosinophilia (in response to infection, autoimmune disease, atopy, hypoadrenalism, tropical eosinophilia, or cancer) have been ruled out. For more information on the research report, visit https://www.kenresearch.com/healthcare/pharmaceuticals/hypereosinophilic-syndrome-pipeline-review-h1-2018/149564-91.html

39 views • 2 slides